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MetabolitesAbstract By the method of 1H NMR prescreening and tracing the diagnostic signals,
6-methylpyridinone derivatives, (8R,9S)-dihydroisoﬂavipucine (1), (8S,9S)-dihydroisoﬂavipucine
(2), 3-(1-hydroxy-4-methyl-2-oxopentylidene)-6-methylpyridine-2,4(1H,3H)-dione (3), 4-hydroxy-3-
(2-hydroxy-4-methylpentanoyl)-6-methylpyridin-2(1H)-one (4), 4-hydroxy-3-[(4-hydroxy-6-methyl-
2-oxo-2H-pyran-3-yl)methyl]-6-methylpyridin-2(1H)-one (5) and a known 6-methylpyranone
derivative 3,30-methylenebis(4-hydroxy-6-methyl-2H-pyran-2-one) (6) were isolated from the marine
fungus Leptosphaerulina sp., which was collected from the starﬁsh Acanthaster planci from the South
China Sea. Compounds 2 and 3 are new compounds. Their structures were elucidated on the basis of
MS, 1D and 2D NMR, and X-ray single crystal diffraction data. The absolute conﬁgurations of
compounds 1 and 2 were determined by analysis on the experimental circular-dichroism spectra.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The starﬁsh Acanthaster planci is found easily in the coral reefs
of the South China Sea. It feeds on coral polyps and large pop-
ulations of A. planci have permanent disastrous effects on the
coral communities. Our investigation on the microorganisms
associated with A. planci led to the puriﬁcation of large num-
ber of fungi, bacteria, and actinomycetes. In our previous
researches on the metabolites of the marine fungi associated
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and biodiversity were obtained (Lan et al., 2012, 2014; Zhao
et al., 2013; Xie et al., 2013; Yan et al., 2015).
Marine fungus Leptosphaerulina sp. was isolated from the
inner tissue of A. planci from the South China Sea. The com-
prehensive literature survey indicates the metabolites research
on the fungus Leptosphaerulina is still rare. This ﬁnding
prompted us to investigate the metabolites of the fungus.
This fungus was cultured in a glucose–peptone–yeast extract
(GPY) medium, and the EtOAc extract of the culture broth
was subjected to chemical structure prescreening by 1H and
13C NMR analysis. The 1H NMR spectra of the crude extract
and the following fractions showed diagnostic singlet signals at
dH 11.5, 6.0 and 2.3. The metabolites puriﬁcation guided by
tracking these signals afforded ﬁve 6-methylpyridinone
derivatives (8R,9S)-dihydroisoﬂavipucine (1), (8S,9S)-
dihydroisoﬂavipucine (2), 3-(1-hydroxy-4-methyl-2-oxopentyli
dene)-6-methylpyridine-2,4(1H,3H)-dione (3), 4-hydroxy-3-(2-
hydroxy-4-methylpentanoyl)-6-methylpyridin-2(1H)-one (4),
4-hydroxy-3-[(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)methyl]-
6-methylpyridin-2(1H)-one (5) and a known 6-methylpyranone
derivative 3,30-methylenebis(4-hydroxy-6-methyl-2H-pyran-2-
one) (6) (Fig. 1). Compounds 2 and 3 are new compounds.
Herein, we describe the isolation, structure determination and
cytotoxic activity evaluation of these compounds.
2. Experimental
2.1. General
Melting points were measured on X-6 micro-melting-point
apparatus (Beijing Fukai Science and Technology
Development, Beijing, PR China) and were uncorrected.
Optical rotations were measured using a Schmidt and
Haensch Polartronic HNQW5 optical rotation spectrometer.
CD spectra were measured on a JASCO J-810 circular dichro-
ism spectrometer. IR spectra were recorded on a PerkinElmer
Frontier FT-IR spectrophotometer. UV spectra were recorded
on a Shimadzu UV–Vis–NIR spectrophotometer. 1D and 2DFigure 1 Chemical structuNMR spectra were recorded on a Varian Inova 500, a
Bruker Avance II 400 spectrometers and a Varian Mercury-
Plus 300 spectrometers. The chemical shifts are relative to
the residual solvent signals (CDCl3: dH 7.26 and dC 77.0;
DMSO-d6: dH 2.50 and dC 39.51). The low- and high-
resolution EI mass spectra were obtained on Thermo DSQ
and Thermo MAT95XP mass spectrometers, respectively.
LR ESI-MS and HR ESI-MS analyses were performed with
Thermo LCQ DECA XP liquid chromatography-mass spec-
trometry and Thermo Fisher LTQ Orbitrap Elite High
Resolution liquid chromatography-mass spectrometry.
Preparative HPLC was performed on a Shimadzu LC-20AT
pumping system equipped with a SPD-20A dual k absorbance
detector and a Shim-pack PRC-ODS HPLC column
(250 · 20 mm, 5 lm). The single crystal data were collected
on a Agilent Technologies Gemini A Ultra system, with Cu
Ka radiation (k= 1.54178 A˚).
2.2. Fungal strain and culture method
The marine fungus Leptosphaerulina sp. (collection Number
2012F7-1B) was isolated from the inner tissue of the starﬁsh
A. planci collected from Hainan Sanya National Coral Reef
Reserve, China. This fungal strain was maintained in 15%
glycerol aqueous solution at 80 C. A voucher specimen
was deposited in the School of Chemistry and Chemical
Engineering, Sun Yat-sen University, Guangzhou, China.
The fermentation medium was glucose 10 g/L, peptone 5 g/L,
yeast extract 2 g/L, seawater 1 L, and pH 7.5 (GPY medium).
The liquid medium was sterilized at 120 C for 30 min. The
mycelia were aseptically transferred to 500 mL Erlenmeyer
ﬂasks containing 200 mL liquid medium. The ﬂasks were then
incubated at 28 C on a rotary shaker (120 rpm) for 20 days.
2.3. Extraction and isolation
60 liter of growth culture broth was ﬁltered through cheese-
cloth. The culture broth was successively extracted three
times with EtOAc. The EtOAc extract was concentrated byres of compounds 1–6.
Table 2 13C NMR data of compounds 1–5.
Position 1a 2a 3b 4c 5a
2 154.1 154.0 177.5 164.7 168.7
3 130.5 130.6 102.7 103.5 107.0
4 152.8 152.8 199.1 178.4 166.2
5 91.8 91.9 100.6 101.6 102.1
6 141.3 141.3 155.8 153.3 144.3
7 18.4 18.4 20.0 19.8 18.2
8 113.3 113.4 164.9 207.4 17.4
9 68.1 68.2 201.0 74.4
10 39.3 39.3 47.1 42.6 165.5
11 23.6 23.6 23.7 25.0 100.7
12 21.4 21.4 23.0 23.7 166.5
13 23.5 23.5 23.0 21.7 101.0
14 160.3
15 19.0
a DMSO-d6, 100 MHz.
b CDCl3, 125 MHz.
c CDCl3, 100 MHz.
290 T. Chen et al.low-temperature rotary evaporation. The extract (18.3 g) was
chromatographed on a silica gel column with light petroleum–
EtOAc (100:0–0:100, v/v) followed by EtOAcAMeOH
(100:0–0:100, v/v) as the eluent to afford 28 fractions (code
Fr. 1–Fr. 28). The chemical structures of the metabolites in
Fr. 1–Fr. 28 were prescreened by 1H NMR. Fr. 3–Fr. 8 was
inferred to contain 6-methylpyridinone derivatives according
to the diagnostic signals at dH 2.3, 6.0 and 11.5. Therefore,
Fr. 3 and Fr. 4 were further puriﬁed by on a normal-phase sil-
ica gel column to obtain 5 (12 mg) and 6 (25 mg), respectively.
Fr. 5 was further puriﬁed by RP-HPLC eluted with
H2OAMeOH (60:40, v/v) to yield 4 (10 mg). Fr. 6 was further
puriﬁed by repeated RP-HPLC eluted with H2OAMeOH
(60:40, v/v) to yield 3 (6 mg). Fr. 7 and Fr. 8 were puriﬁed
by RP-HPLC eluted with H2OAMeOH (50:50, v/v) to yield
1 (32 mg) and 2 (16 mg).
2.4. Cytotoxicity assay
The in vitro cytotoxicities of 1–6 were screened using the
colorimetric MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
2H-tetrazolium bromide) assay. The tested human cancer cell
lines were seeded in 96-well plates at a density of 3 · 107 cells/L,
and the compounds were added at various concentrations
(0.125–50 mg/L). After 48 h, MTT was added to the culture
medium at a ﬁnal concentration of 0.5 mg/mL, and the plates
were incubated for 4 h at 37 C. The supernatant was removed.
The formazan crystals were dissolved in DMSO (150 lL) with
gentle shaking at r.t. The absorbance at 570 nm was recorded
with a microplate reader (Bio-Rad), and the data were
analyzed with the SPSS 13.0 software package.Table 1 1H NMR data of compounds 1–5.
Position 1a 2a
1 NH 11.52 (brs) 11.51 (brs)
5 6.01 (s) 6.00 (d, 0.8)
7 2.13 (s) 2.14 (s)
8 5.99 (d, 3.2) 5.95 (d, 3.0)
9 3.71 (ddd, 13.4, 6.4, 3.2) 3.71 (dt, 10.0, 3.0)
10 a: 1.40 (ddd, 13.4, 10.0, 4.0); b: 1.19
(ddd, 13.4, 10.0, 3.2)
a: 1.40 (ddd, 14.0, 10.0,
1.19 (ddd, 14.0, 10.0, 3.
11 1.80 (m) 1.81 (m)
12 0.86 (d, 6.4) 0.86 (d, 6.8)
13 0.91 (d, 6.4) 0.91 (d, 6.8)
15
4-OH
8-OH
9-OH 5.22 (d, 6.4) 5.20 (brs)
12-OH
a DMSO-d6, 400 MHz.
b CDCl3, 500 MHz.
c CDCl3, 400 MHz.2.5. (8R,9S)-dihydroisoﬂavipucine (1)
Colorless crystal; mp 170–171 C; [a]20D 282 (c 0.011, MeOH);
UV (MeOH) kmax (e) 308 nm (7557), 254 nm (2681), 217 nm
(23,298); IR tmax 3280, 3020, 2962, 2932, 1670, 1617, 1520,
1470, 1423, 1290, 1208, 1176, 1148, 1108, 1080, 1025, 1007,
986, 924, 795 cm1; 1H and 13C NMR data, see Tables 1 and
2; LREIMS m/z 239 [M]+, 224, 208, 196, 182, 168, 152, 141,
124, 112, 96, 84, 68, 57. HREIMS m/z 239.1151 [M]+ (calcd3b 4c 5a
11.92 (brs) 11.51 (brs) 11.96
(brs)
5.90 (s) 5.94 (s) 5.97
(s)
2.30 (s) 2.33 (s) 2.16
(s)
3.43
(s)
5.91 (d, 9.6)
4.0); b:
0)
2.61 (d, 6.5) a: 1.44 (ddd, 14.0, 9.6, 4.8); b:
1.19 (ddd, 14.0, 9.6, 4.8)
2.25 (nine
peaks, 6.5)
1.99 (m)
1.01 (d, 6.5) 1.00 (d, 6.4)
1.03 (d, 6.5) 1.01 (d, 6.4) 5.97
(s)
2.13
(s)
15.01 (brs) 10.39
(brs)
13.46 (brs)
2.19 (brs)
10.39
(brs)
NMR screening approach for discovery of new 6-methylpyridinone derivatives 291for C12H17NO4, 239.1152). Crystal of 1 was obtained from
MeOH solution. C12H17NO4, M= 239.27, colorless block,
monoclinic, space group P2(1)/n, a= 13.7719(5) A˚,
b= 5.7096(2) A˚, c= 16.7688(6) A˚, b= 109.255(4),
V= 1244.80(8), Z= 4, Dcalcd. = 1.277 g/cm
3, crystal size
0.46 · 0.41 · 0.38 mm3, F(000) = 512, T= 293(2) K.2.6. (8S,9S)-dihydroisoﬂavipucine (2)
Colorless crystal; mp 166–167 C; [a]20D + 173 (c 0.031,
MeOH); UV (MeOH) kmax (e) 306 nm (1308), 254 nm (502),
217 nm (4157); IR tmax 3280, 3020, 2962, 2932, 1670, 1617,
1520, 1470, 1423, 1290, 1208, 1176, 1148, 1108, 1080, 1025,
1007, 986, 924, 795 cm1; 1H and 13C NMR data, see Tables
1 and 2; LREIMS m/z 239 [M]+, 224, 208, 196, 182, 168,
152, 141, 124, 112, 96, 84, 68, 57; HREIMS m/z 239.1151
[M]+ (calcd for C12H17NO4, 239.1152). Compound 2 was crys-
tallized from methanol to afford some crystals which were suit-
able for single-crystal X-ray crystallographic analysis.
C12H21NO5, M= 271.31, colorless block. Monoclinic, space
group P2(1)/c, a= 8.5655(3) A˚, b= 18.8084(5) A˚,
c= 9.6519(3) A˚, b= 116.124(4), V= 1396.10(8), Z= 4,
Dcalcd. = 1.291 g/cm
3, crystal size 0.42 · 0.36 · 0.36 mm3,
F(000) = 584, T= 173(2) K.
2.7. 3-(1-Hydroxy-4-methyl-2-oxopentylidene)-6-methylpyridine-
2,4(1H,3H)-dione (3)
White solid; mp 182–183 C; [a]20D + 206.5 (c 0.026, MeOH);
UV (MeOH) kmax (e): 318 nm (19,779), 275 nm (4381),
232 nm (18,243), 206 nm (21,567). IR tmax 3385, 3075, 2956,
1718, 1675, 1634, 1608, 1568, 1490, 1467, 1450, 1354, 1286,
1249, 1182, 1158, 823, 753 cm1; 1H and 13C NMR data, see
Tables 1 and 2; LR(+)ESIMS: m/z 497 [2 M+Na]+, 260
[M+ Na]+, 238 [M+ H]+, 224, 208, 196, 182, 168, 152,
141, 124, 112, 96, 84, 68, 57; HR()ESIMS m/z
236.0927[M  H] (calcd for C12H14NO4, 236.0928).2.8. 4-Hydroxy-3-(2-hydroxy-4-methylpentanoyl)-6-
methylpyridin-2(1H)-one (4)
White solid; 1H and 13C NMR data, see Tables 1 and 2;
LREIMS m/z 239 [M]+, 221, 208, 198, 182, 173, 159, 152,
138, 125, 108, 96, 84, 68, 53.
2.9. 4-Hydroxy-3-[(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-
yl)methyl]-6-methylpyridin-2(1H)-one (5)
White solid; 1H and 13C NMR data, see Tables 1 and 2;
LR(+)ESIMS m/z 264 [M+ H]+; HR(+)ESIMS m/z0 10 20 30 40
0.0
2.5
5.0
7.5
mV
Figure 2 The HPLC trace286.0676 [M+ Na]+, 264.0810 [M+ H]+ (calcd for
C13H14NO5, 264.0872).
2.10. 3,30-Methylenebis(4-hydroxy-6-methyl-2H-pyran-2-one)
(6)
Colorless crystals; mp 161–162 C; 1H NMR (CDCl3,
300 MHz): dH 10.71 (s, OH-4 and OH-40, 2H), 5.99 (s, H-5
and H-50, 2H), 3.50 (s, H-8, 2H), 2.25 (s, H-7 and H-70, 6H).
13C NMR (CDCl3, 75 MHz): dC 169.8 (C-2, and C-20), 168.4
(C-4, and C-40), 161.0 (C-6, and C-60), 101.5 (C-3, and C-30),
102.5 (C-5, and C-50), 18.6 (C-8), 19.8 (C-7, and C-70).
LREIMS: m/z 264 [M]+, 236, 221, 203, 194, 180, 179, 152,
151, 139, 137, 124, 111, 98, 85, 69. Compound 6 was crystal-
lized from EtOAc to afford some crystals which were suitable
for single crystal X-ray crystallographic analysis. C13H12O6,
M= 264.23, colorless block, Monoclinic, space group
P2(1)/c, a= 13.8506 (3) A˚, b= 11.7211 (2) A˚, c= 7.2516
(2) A˚, b= 91.766(2), V= 1176.70(5), Z= 4, Dcalcd. = 1.491
g/cm3, crystal size 0.45 · 0.39 · 0.38 mm3, F(000) = 552,
T= 293(2) K.
3. Results and discussion
Compounds 1 and 2 were isolated from the fractions 7 and 8
by normal-phase silica gel column chromatography followed
by RP-HPLC eluted with H2OAMeOH (50:50, v/v). In the
HPLC trace, compounds 1 and 2 showed two independent
peaks with the retention time 65.66 and 70.97 min, respec-
tively, eluted with H2OAMeOH (50:50, v/v) (Fig. 2).
However, their MS, 1D and 2D NMR, including HMQC,
HMBC, 1HA1H COSY and NOESY (Tables 1 and 2), are
almost identical. So, we conceive that compounds 1 and 2
are conformational isomers.
Compound 1 was identiﬁed as (8R,9S)-dihydroiso-
ﬂavipucine, which was previously reported in 1977 as a artiﬁ-
cial degradation product of the fungal metabolite isoﬂavipu-
cine (Findlay et al., 1977), and it was ﬁrstly obtained in 2011
as a natural product from an endophytic fungus Phoma sp.
(Loesgen et al., 2011). The single crystals of 1 were obtained
from the MeOH solution. In the crystal, the molecules are
joined together by strong OAH  O‚C hydrogen bonds to
form a highly puckered layer-type structure (Fig. 3a). The
experimental CD spectrum of 1 (Fig. 4a) was identical to the
reference data (Loesgen et al., 2011).
Compound 2 was obtained as a colorless crystal. Its molec-
ular formula was established as C12H17NO4 based on the
HREIMS peak at m/z 239.1151 [M]+, the 1H and 13C NMR
spectroscopic data (Tables 1 and 2). The UV spectrum showed
the characteristic absorption bands at kmax 306 and 254 nm
indicated the presence of a conjugated system. The strong IR
absorption at 1670 cm1 indicated the presence of a carbonyl50 60 70 min
1, RT=65.66
2, RT=70.97
of compounds 1 and 2.
(a)                                     (b) 
Figure 3 Crystal structures of compounds 1 (a) and 2 (b). Thermal ellipsoids are plotted at a 30% probability level.
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Figure 4 Circular dichroism (CD) spectra of compounds 1 (a) and 2 (b) in MeCN solution.
292 T. Chen et al.group. The 13C NMR and DEPT spectra displayed three
methyls, one methylene, four methines, and four quaternary
carbons. In the 1HA1H COSY spectrum, the cross peaks of
H-8/H-9, H-9/H-10, H-10/H-11, H-11/H-12 and H-11/H-13
indicated the presence of a partial structure ACHCHCH2-
CH(CH3)2 in this molecule (Fig. 5). The methyl singlet at dH
2.13 showing a weak cross peak with the oleﬁnic proton at
dH 6.01 in
1HA1H COSY spectrum, combined with the
HMBC correlations of H-7/C-6, H-5/C-6, H-5/C-4 and H-
5/C-3, revealed the other partial structure AC(CH3)‚
CHAC‚CA. The amide and the partial structure
AC(CH3)‚CHAC‚CA established the 6-methylpyridinone
skeleton. The partial structure ACHCHCH2CH(CH3)2 con-
nected with 6-methylpyridinone skeleton at C-3 and C-4 byN
H
O
O
O
H
HO H
Figure 5 1HA1H COSY (bold line) and main HMBC (arrow)
correlations of compound 2.the two oxygen bridges. The hydroxyl group at dH 5.22 was
connected to C-9 (dC 68.1) based on the HMBC correlations
with C-8, C-9 and C-10. Therefore, the planar structure of
compound 2 was determined as dihydroisoﬂavipucine.
Fortunately, the single crystals of 2 were also obtained from
the MeOH solution. The molecules are joined together by
strong OAH  O‚C hydrogen bonds. Additional strong
OAH  O hydrogen bonds are formed between MeOH mole-
cule and the OH group of the molecule to form a wavy
layer-type structure (Fig. 3b). The CD spectrum of 2
(Fig. 4b) was also ﬁt to the quantum-chemically calculated
CD spectrum of (8S,9S)-dihydroisoﬂavipucine (2) (Loesgen
et al., 2011).
Compound 3 was isolated as a white solid. The molecular
formula was assigned as C12H15NO4 by HR()ESIMS peak
at m/z 236.0927 [M  H] and NMR data (Tables 1 and 2),
comprising six degrees of unsaturation. The 13C NMR and
DEPT spectra displayed three methyls, one methylene, two
methines, and six quaternary carbons. In the 1H NMR spec-
trum, the characteristic signals at dH 11.92, 5.90, and 2.30 sug-
gest compound 3 is also a 6-methylpyridinone derivative. In
1HA1H COSY spectrum, the two methyl groups at dH 1.01
(d, 6.5 Hz) and 1.03 (d, 6.5 Hz), and a methene at dH 2.61
(d, 6.5 Hz) showed correlations with the methine at dH 2.25
(nine, 6.5 Hz), so, the partial structure ACH2CH(CH3)2 was
established (Fig. 6). The H-10 showed HMBC correlations
with the carbonyl carbon at dC 201.0 (C-9) and the quaternary
carbon at dC 164.9 (C-8). In addition, oleﬁnic proton at dH
5.90 (s, H-5) showed HMBC correlations with the carbonyl
carbons at dC 199.1 (C-4) and 177.4 (C-2), and quaternary car-
bons at dC 102.7 (C-3) and 155.8 (C-6). The hydroxyl group at
N O
O OH
O
H
Figure 6 1HA1H COSY (bold line) and main HMBC (arrow)
correlations of compound 3.
NMR screening approach for discovery of new 6-methylpyridinone derivatives 293dH 13.46 was connected at C-8. Based on the analysis above,
compound 3 was elucidated as 3-(1-hydroxy-4-methyl-2-oxo
pentylidene)-6-methylpyridine-2,4(1H,3H)-dione. The NMR
data are not enough to determine the E/Z conﬁguration of
the double bound between C-3 and C-8. It is also very difﬁcult
to obtain a suitable crystal for X-ray single diffraction experi-
ment, so, the conﬁguration remains uncertain.
Compound 4 was obtained as a white solid. The molecular
formula was assigned as C12H17NO4 by HREIMS peak at m/z
239.1151 [M]+ and NMR data (Tables 1 and 2), comprising
ﬁve degrees of unsaturation. The 13C NMR and DEPT spectra
displayed three methyls, one methylene, three methines, and
ﬁve quaternary carbons. In 1H NMR spectrum, the character-
istic signals at dH 11.51, 5.94, and 2.33 suggest compound 4 is
also a 6-methylpyridinone derivative. In 1HA1H COSY spec-
trum, the correlations of H-9/H-10, H-10/H-11, H-11/H-12,
and H-11/H-13 established the side chain of ACHCH2
CH(CH3)2. The phenolic hydroxyl group at dH 15.01 was
attached at C-4 and formed an intramolecular hydrogen bond
with the carbonyl group at C-8. The other hydroxyl group at
dH 2.19 was connected at C-9, however, its stereochemistry
was not determined due to the limited sample. Compound 4
was elucidated as 4-hydroxy-3-(2-hydroxy-4-methylpentanoyl)-
6-methylpyridin-2(1H)-one. Compound 4 was previously
obtained in 1978 as a synthesized product by Girotra and
Wendler (1978). However, this is the ﬁrst time of presenting
the detailed 1H and 13C NMR assignment.
Compound 5 was identiﬁed as 4-hydroxy-3-[(4-hydroxy-6-
methyl-2-oxo-2H-pyran-3-yl)methyl]-6-methylpyridin-2(1H)-
one (the other name is penicipyrone), which was previously
isolated from marine fungus Penicillum sp. PSU-F40
(Trisuwan et al., 2010). However, our NMR data recorded
in DMSO-d6 (Tables 1 and 2) were slightly different from
the reference values recorded in CDCl3 + CD3OD.Figure 7 Crystal structure of compound 6. Thermal ellipsoids
are plotted at a 30% probability level.Compound 6 is 3,30-methylenebis(4-hydroxy-6-methyl-2H-
pyran-2-one). Its NMR data were identical to the reference
value (Minassi et al., 2012). The single crystals of 6 were
obtained from the EtOAc solution. In the crystal, a pair of
very strong OAH  O‚C intramolecular hydrogen bonds ﬁxs
the orientation of the molecule. Neighboring molecules are
joined together by weak CAH  O‚C hydrogen bonds to
form a puckered layer (Fig. 7).
Fifteen cancer cell lines, including SW620, SW480, LoVo,
Hep3B, A549, HepG2, Bel-7402, CNE1, CNE2, SUNE1,
MCF7, MDA-MB-231, MDA-MB-435, MDA-MB-453 and
HeLa were used to examine the cytotoxic activities of com-
pounds 1–6 in vitro. Unfortunately, this assay revealed that
these compounds are inactive (IC50 > 20 lg/mL).4. Conclusions
Most of the marine fungi can produce proliﬁc metabolites with
various biosynthetic pathways. Some of those compounds can
only be found at very low levels, so that massive harvesting is
needed to obtain sufﬁcient amounts, and various advanced
technologies, including the bioassay and chemical structure
prescreening are developed to promote the efﬁciency of
metabolites isolation. 6-methylpyridinone derivatives showed
the characteristic singlet signals around dH 11.5, 6.0 and
2.13. Tracing these diagnostic signals, compounds 1–6 were
obtained with a high efﬁciency.
CCDC 1047171–1047173 contains crystallographic data for
(8R,9S)-dihydroisoﬂavipucine (1), (8S,9S)-dihydroisoﬂavipucine
(2) and 6-methylpyranone derivative 3,30-methylenebis(4-hydroxy-
6-methyl-2H-pyran-2-one) (6), respectively. These data can be
obtained free of charge from The Cambridge Crystallographic
Data Centre via www.ccdc.cam.ac.uk/data_request/cif.Acknowledgments
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